Hideyasu Oh

4.4k total citations
45 papers, 2.8k citations indexed

About

Hideyasu Oh is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hideyasu Oh has authored 45 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Ophthalmology, 22 papers in Radiology, Nuclear Medicine and Imaging and 21 papers in Molecular Biology. Recurrent topics in Hideyasu Oh's work include Retinal Diseases and Treatments (26 papers), Angiogenesis and VEGF in Cancer (18 papers) and Retinal Imaging and Analysis (13 papers). Hideyasu Oh is often cited by papers focused on Retinal Diseases and Treatments (26 papers), Angiogenesis and VEGF in Cancer (18 papers) and Retinal Imaging and Analysis (13 papers). Hideyasu Oh collaborates with scholars based in Japan, United States and Germany. Hideyasu Oh's co-authors include Hitoshi Takagi, Yoshihito Honda, Kiyoshi Suzuma, Atsushi Otani, Miyo Matsumura, Shinji Koyama, A. Otani, Mihori Kita, Nagahisa Yoshimura and Yuichiro Ogura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Hideyasu Oh

44 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyasu Oh Japan 25 1.5k 1.2k 988 297 282 45 2.8k
Izumi Suzuma Japan 26 1.2k 0.8× 1.3k 1.0× 727 0.7× 254 0.9× 271 1.0× 29 2.8k
Miyo Matsumura Japan 34 2.7k 1.8× 1.6k 1.3× 1.6k 1.6× 159 0.5× 210 0.7× 138 4.1k
Hitoshi Takagi Japan 28 2.3k 1.5× 1.2k 1.0× 1.6k 1.7× 130 0.4× 236 0.8× 85 3.4k
Sean F. Hackett United States 28 1.5k 1.0× 2.1k 1.7× 832 0.8× 164 0.6× 692 2.5× 54 3.2k
Hitoshi Takagi Japan 28 1.4k 0.9× 2.2k 1.8× 813 0.8× 502 1.7× 528 1.9× 43 3.8k
Yasuaki Hata Japan 35 2.5k 1.7× 1.4k 1.1× 2.0k 2.0× 102 0.3× 217 0.8× 62 3.7k
Edith Aguilar United States 30 1.6k 1.0× 1.7k 1.4× 1.0k 1.0× 81 0.3× 392 1.4× 57 3.3k
Keijiro Ishikawa Japan 26 1.3k 0.9× 964 0.8× 716 0.7× 131 0.4× 207 0.7× 91 2.2k
Sabera T. Shah United States 4 2.3k 1.5× 1.1k 0.9× 1.5k 1.6× 131 0.4× 254 0.9× 5 3.1k
M. Ali Behzadian United States 22 794 0.5× 937 0.8× 478 0.5× 78 0.3× 212 0.8× 35 2.0k

Countries citing papers authored by Hideyasu Oh

Since Specialization
Citations

This map shows the geographic impact of Hideyasu Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyasu Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyasu Oh more than expected).

Fields of papers citing papers by Hideyasu Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyasu Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyasu Oh. The network helps show where Hideyasu Oh may publish in the future.

Co-authorship network of co-authors of Hideyasu Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyasu Oh. A scholar is included among the top collaborators of Hideyasu Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyasu Oh. Hideyasu Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimura, Masahiko, Hideyasu Oh, Tetsuo Ueda, et al.. (2024). Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial. Japanese Journal of Ophthalmology. 68(5). 511–522. 8 indexed citations
2.
3.
Miyamoto, Noriko, Michiko Mandai, Akio Oishi, et al.. (2018). Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP study. British Journal of Ophthalmology. 103(6). 844–848. 22 indexed citations
4.
5.
6.
Oh, Hideyasu. (2014). Idiopathic Macular Hole. Developments in ophthalmology. 54. 150–158. 19 indexed citations
7.
Oishi, Akio, Hiroshi Kojima, Michiko Mandai, et al.. (2013). Comparison of the Effect of Ranibizumab and Verteporfin for Polypoidal Choroidal Vasculopathy: 12-Month LAPTOP Study Results. American Journal of Ophthalmology. 156(4). 644–651.e1. 123 indexed citations
8.
Yoshitake, Shin, Hideyasu Oh, & Mihori Kita. (2012). Endoscope-assisted vitrectomy for retinal detachment in an eye with microcornea. Japanese Journal of Ophthalmology. 56(6). 613–616. 10 indexed citations
9.
Tsujikawa, Akitaka, Atsushi Sakamoto, Masafumi Ota, et al.. (2010). Serous Retinal Detachment Associated With Retinal Vein Occlusion. American Journal of Ophthalmology. 149(2). 291–301.e5. 94 indexed citations
10.
Unoki, Noriyuki, Kazuaki Nishijima, Masato Kita, et al.. (2009). Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy. British Journal of Ophthalmology. 93(6). 765–770. 13 indexed citations
11.
Sakamoto, Atsushi, Kazuaki Nishijima, Mihori Kita, et al.. (2009). Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefe s Archive for Clinical and Experimental Ophthalmology. 247(10). 1325–1330. 115 indexed citations
12.
Zacchigna, Serena, Hideyasu Oh, Michaela Wilsch‐Bräuninger, et al.. (2009). Loss of the Cholesterol-Binding Protein Prominin-1/CD133 Causes Disk Dysmorphogenesis and Photoreceptor Degeneration. Journal of Neuroscience. 29(7). 2297–2308. 144 indexed citations
13.
Ojima, Tomonari, Hitoshi Takagi, Kiyoshi Suzuma, et al.. (2006). EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier Breakdown. American Journal Of Pathology. 168(1). 331–339. 63 indexed citations
14.
Kimura, T., Masayo Takahashi, Hitoshi Takagi, et al.. (2005). IS REMOVAL OF INTERNAL LIMITING MEMBRANE ALWAYS NECESSARY DURING STAGE 3 IDIOPATHIC MACULAR HOLE SURGERY?. Retina. 25(1). 54–58. 15 indexed citations
15.
Otani, Atsushi, Hitoshi Takagi, Hideyasu Oh, et al.. (2003). VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANGIOPOIETIN 2 EXPRESSION IN LASER-TREATED CHOROIDAL NEOVASCULAR MEMBRANES. Retina. 23(3). 402–404. 2 indexed citations
16.
Takagi, Hitoshi, Kiyoshi Suzuma, Hideyasu Oh, et al.. (2002). Essential Role of Leptin in Ischemia-Induced Retinal Neovascularization. Investigative Ophthalmology & Visual Science. 43(13). 2405–2405. 2 indexed citations
17.
Koyama, Shinji, Hitoshi Takagi, Atsushi Otani, et al.. (2002). Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine. British Journal of Pharmacology. 137(6). 901–909. 11 indexed citations
18.
Manabe, Shin-ichi, et al.. (2000). Ultrasound biomicroscopic analysis of posterior chamber intraocular lenses with transscleral sulcus suture. Ophthalmology. 107(12). 2172–2178. 41 indexed citations
19.
Oh, Hideyasu, Hitoshi Takagi, Kiyoshi Suzuma, et al.. (1999). Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells. Journal of Biological Chemistry. 274(22). 15732–15739. 403 indexed citations
20.
Suzuma, Kiyoshi, Hitoshi Takagi, Atsushi Otani, Hideyasu Oh, & Yoshihito Honda. (1999). Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization. American Journal Of Pathology. 154(2). 343–354. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Izumi Suzuma Breakdown of academic impact, for papers by Miyo Matsumura Breakdown of academic impact, for papers by Hitoshi Takagi Breakdown of academic impact, for papers by Sean F. Hackett Breakdown of academic impact, for papers by Hitoshi Takagi Breakdown of academic impact, for papers by Yasuaki Hata Breakdown of academic impact, for papers by Edith Aguilar Breakdown of academic impact, for papers by Keijiro Ishikawa Breakdown of academic impact, for papers by Sabera T. Shah Breakdown of academic impact, for papers by M. Ali Behzadian
Rankless by CCL
2026